DellaValle, B., Brix, G. S., Brock, B., Jensen, M. G., Landau, A. M., Møller, A., Rungby, J. & Larsen, A. (2016). Glucagon-Like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis Rats. Frontiers in Pharmacology, 7(NOV), 433. Article 433. https://doi.org/10.3389/fphar.2016.00433

Del Dotto, P., Pavese, N., Gambaccini, G., Bernardini, S., Metman, L. V., Chase, T. N. & Bonuccelli, U. (2001). Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study. Movement Disorders, 16(3), 515-520. https://doi.org/10.1002/mds.1112

Danielsen, E. H., Cumming, P., Andersen, F., Bender, D., Brevig, T., Falborg, L., Gee, A., Gillings, N. M., Hansen, S. B., Hermansen, F., Johansen, J., Johansen, T. E., Dahl-Jørgensen, A., Jørgensen, H. A., Meyer, M., Munk, O. L., Pedersen, E. B., Poulsen, P. H., Rodell, A. B. ... Møller, A. (2000). The DaNeX Study of Embryonic Mesencephalic Dopaminergic Tissue Grafted to a Minipig model of Parkinson's disease: Preliminary Findings of Effect of MPTP-Poisoning on Striatal Dopaminergic Markers. Cell Transplantation, 9(2), 247-259.

Dani, M., Brooks, D. J. & Edison, P. (2016). Tau imaging in neurodegenerative diseases. European journal of nuclear medicine and molecular imaging, 43(6), 1139-1150. https://doi.org/10.1007/s00259-015-3231-2

Dani, M., Brooks, D. J. & Edison, P. (2017). Suspected non-Alzheimer's pathology - Is it non-Alzheimer's or non-amyloid? Ageing Research Reviews, 36, 20-31. https://doi.org/10.1016/j.arr.2017.02.003

Dani, M., Wood, M., Mizoguchi, R., Fan, Z., Walker, Z., Morgan, R., Hinz, R., Biju, M., Kuruvilla, T., Brooks, D. J. & Edison, P. (2018). Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease. Brain, 141(9), 2740-2754. https://doi.org/10.1093/brain/awy188

Dani, M., Edison, P. & Brooks, D. J. (2016). Imaging biomarkers in tauopathies. Parkinsonism and Related Disorders, 22, S26-S28. https://doi.org/10.1016/j.parkreldis.2015.08.011

Dani, M., Wood, M., Mizoguchi, R., Fan, Z., Edginton, T., Hinz, R., Win, Z., Brooks, D. J. & Edison, P. (2019). Tau Aggregation Correlates with Amyloid Deposition in Both Mild Cognitive Impairment and Alzheimer's Disease Subjects. Journal of Alzheimer's Disease, 70(2), 455-465. https://doi.org/10.3233/JAD-181168

Damholdt, M. F., Callesen, M. B. & Møller, A. (2014). Personality characteristics of depressed and non-depressed patients with Parkinson's Disease. Journal of Neuropsychiatry and Clinical Neurosciences, 26(4), 329-334. https://doi.org/10.1176/appi.neuropsych.13040085

Dall, A. M., Danielsen, E. H., Sørensen, J. C., Andersen, F., Møller, A., Zimmer, J., Gjedde, A., the DaNeX Group & Cumming, P. (2002). Quantitative [¹⁸F]Fluorodopa/PET and histology of fetal mesencephalic dopaminergic grafts to the striatum of MPTP-poisoned Minipigs. Cell Transplantation, 11, 733-746.

Dall, A. M., Danielsen, E. H., Sørensen, J. C. H., Andersen, F., Møller, A., Zimmer, J., Gjedde, A. H. & Cumming, P. (2002). Quantitative [18F]fluorodopa/PET and histology of fetal mesencephalic dopaminergic grafts to the striatum of MPTP-poisoned minipigs. Cell Transplantation, 11(8), 733-46.

Dai, W., Zhou, H., Møller, A., Wei, P., Hu, K., Feng, K., Han, J., Li, Q. & Liu, X. (2022). Patients with Methamphetamine Use Disorder Show Highly Utilized Proactive Inhibitory Control and Intact Reactive Inhibitory Control with Long-Term Abstinence. Brain sciences, 12(8), Article 974. https://doi.org/10.3390/brainsci12080974

Dagø, L., Bonde, C., Peters, D., Møller, A., Bomholt, S. F., Hartz, B. P., Meyer, M., Drejer, J. & Grønborg, M. (2002). NS1231, a novel compound with neurotrophic-like effects in vitro and in vivo. Neurochemical, 81, 17-24.

Daglish, M. R. C., Williams, T. M., Wilson, S. J., Taylor, L. G., Eap, C. B., Augsburger, M., Giroud, C., Brooks, D. J., Myles, J. S., Grasby, P., Lingford-Hughes, A. R. & Nutt, D. J. (2008). Brain dopamine response in human opioid addiction. British Journal of Psychiatry, 193(1), 65-72. https://doi.org/10.1192/bjp.bp.107.041228

Dagher, A., Owen, A. M., Boecker, H. & Brooks, D. J. (2001). The role of the striatum and hippocampus in planning: A PET activation study in Parkinson's disease. Brain, 124(5), 1020-1032.

Dagher, A., Owen, A. M., Boecker, H. & Brooks, D. J. (1999). Mapping the network for planning: A correlational PET activation study with the Tower of London task. Brain, 122(10), 1973-1987. https://doi.org/10.1093/brain/122.10.1973

Dagher, A., Owen, A. M. & Brooks, D. J. (1997). Spatial planning in normal and parkisonian subjects: A PET study. NeuroImage, 5(4 PART II).

Cury, R. G., Pavese, N., Aziz, T. Z., Krauss, J. K., Moro, E. & the Neuromodulation of Gait Study Group from Movement Disorders Society (2022). Gaps and roadmap of novel neuromodulation targets for treatment of gait in Parkinson’s disease. npj Parkinson's Disease , 8(1), Article 8. https://doi.org/10.1038/s41531-021-00276-6

Cumming, P., Danielsen, E. H., Vafaee, M., Faldborg, L., Steffensen, E., Sørensen, J. C., Gillings, N., Bender, D., Marthi, K., Andersen, F., Munk, O., Smith, D., Møller, A. & Gjedde, A. (2001). Normalization of markers for dopamine innervation in striatum of MPTP-lesioned miniature pigs with intrastriatal grafts. Acta Neurologica Scandinavica, 103, 309-315.

Cintra, A., Lindberg, J., Chadi, G., Tinner, B., Møller, A., Gustafsson, J. Å., DeKloet, E. R., Oitzl, M., Nishikawa, K., Agnati, L. F. & Fuxe, K. (1994). Basic fibroblast growth factor and steroid receptors in the aging hippocampus of the brown norway rat: Immunocytochemical analysis in combination with stereology. Neurochem. Int., 25, 39-45.

Cintra, A., Aguirre, J. A., Finnman, U.-B., Hagman, M., Agnati, L. F., Höglund, C., Møller, A. & Fuxe, K. (1999). Subchronic toluene exposure in low concentrations produces signs of reduced dysfunction in the 6-hydroxydopamine lesioned nigrostriatal dopaminergic system of the rat. Neuroscience Letter, 274, 5-8.

Chételat, G., Arbizu, J., Barthel, H., Garibotto, V., Law, I., Morbelli, S., van de Giessen, E., Agosta, F., Barkhof, F., Brooks, D. J., Carrillo, M. C., Dubois, B., Fjell, A. M., Frisoni, G. B., Hansson, O., Herholz, K., Hutton, B. F., Jack, C. R., Lammertsma, A. A. ... Drzezga, A. (2020). Amyloid-PET and ¹⁸F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. Lancet Neurology, 19(11), 951-962. https://doi.org/10.1016/S1474-4422(20)30314-8

Cheesman, A. L., Barker, R. A., Lewis, S. J. G., Robbins, T. W., Owen, A. M. & Brooks, D. J. (2005). Lateralisation of striatal function: Evidence from ¹⁸F-dopa PET in Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry, 76(9), 1204-1210. https://doi.org/10.1136/jnnp.2004.055079

Chaudhuri, K. R., Rojo, J. M., Schapira, A. H. V., Brooks, D. J., Stocchi, F., Odin, P., Antonini, A., Brown, R. G. & Martinez-Martin, P. (2016). A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need (vol 8, e57221, 2013). P L o S One, 11(2), Article 0150130. https://doi.org/10.1371/journal.pone.0150130

Chaudhuri, K. R., Buxton-Thomas, M., Dhawan, V., Peng, R., Meilak, C. & Brooks, D. J. (2005). Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: Clinical follow up study of 13 cases. Journal of Neurology, Neurosurgery & Psychiatry, 76(1), 115-117. https://doi.org/10.1136/jnnp.2004.046292

Chaudhuri, K. R., Poewe, W. & Brooks, D. (2018). Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features. Movement Disorders, 33(6), 909-919. https://doi.org/10.1002/mds.27386

Chaudhuri, K. R., Hu, M. T. M. & Brooks, D. J. (2000). Atypical parkinsonism in Afro-Caribbean and Indian origin immigrants to the UK. Movement Disorders, 15(1), 18-23. https://doi.org/10.1002/1531-8257(200001)15:1<18::AID-MDS1005>3.0.CO;2-Z

Chaudhuri, K. R., Richards, M. & Brooks, D. J. (1997). How far are we in understanding the cause of Parkinson's disease? Journal of neurology, neurosurgery, and psychiatry, 62(1). https://doi.org/10.1136/jnnp.62.1.104-a

Chaudhuri, K. R., Edwards, R., Scott, J., Brooks, D. J., Rees, A. & Pusey, C. D. (1993). Adult moyamoya disease. British Medical Journal, 307(6908), 852-854.

Chaudhuri, K. R., Edwards, R., Sawle, G. V., Brooks, D. J. & Frackowiak, R. S. J. (1994). Carpopedal spasm as presenting feature of adult moyamoya disease. Cerebrovascular Diseases, 4(2), 106-107. https://doi.org/10.1159/000108462

Chang, N. H. S., Kumakura, Y., Møller, A., Linnet, J., Bender, D., Doudet, D. J., Vafaee, M. S. & Gjedde, A. (2022). On the learning of addictive behavior: Sensation-seeking propensity predicts dopamine turnover in dorsal striatum. Brain Imaging and Behavior, 16(1), 355-365. https://doi.org/10.1007/s11682-021-00509-5

Chadi, G., Møller, A., Rosén, L., Janson, A. M., Agnati, L. A., Goldstein, M., Ögren, S.-O., Pettersson, R. F. & Fuxe, K. (1993). Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion. Experimental Brain Research, 97, 145-158.

Ceravolo, R., Piccini, P., Bailey, D. L., Jorga, K. M., Bryson, H. & Brooks, D. J. (2002). 18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease. Synapse, 43(3), 201-207. https://doi.org/10.1002/syn.10034

Cenci, M. A. & Brooks, D. (2013). Bad news for neuroprotective therapies in PD? Journal of Parkinson's Disease, 3(3), 271-3. https://doi.org/10.3233/JPD-139001

Ceballos-Baumann, A. O., Sheean, G., Passingham, R. E., Marsden, C. D. & Brooks, D. J. (1997). Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp. A PET study. Brain, 120(4), 571-582. https://doi.org/10.1093/brain/120.4.571

Ceballos-Baumann, A. O. & Brooks, D. J. (1998). Activation positron emission tomography scanning in dystonia. Advances in neurology, 78, 135-152.

Ceballos-Baumann, A. O. & Brooks, D. J. (1997). Basal ganglia function and dysfunction revealed by PET activation studies. Advances in neurology, 74, 127-139.

Carboncini, M. C., Manzoni, D., Strambi, S., Bonuccelli, U., Pavese, N., Andre, P. & Rossi, B. (2001). The relation between EMG activity and kinematic parameters strongly supports a role of the action tremor in parkinsonian bradykinesia. Movement Disorders, 16(1), 47-57. https://doi.org/10.1002/1531-8257(200101)16:1<47::AID-MDS1012>3.0.CO;2-V

Capaday, C., Richardson, M. P., Rothwell, J. C. & Brooks, D. J. (2000). Long-term changes of GABAergic function in the sensorimotor cortex of amputees. A combined magnetic stimulation and ¹¹C-flumazenil PET study. Experimental Brain Research, 133(4), 552-556. https://doi.org/10.1007/s002210000477

Campbell-Meiklejohn, D., Simonsen, A., Scheel-Krüger, J., Wohlert, V., Gjerløff, T., Frith, C. D., Roepstorff, A., Rogers, R. & Møller, A. (2012). In for a penny, in for a pound: methylphenidate reduces the inhibiting effect of high stakes on persistent risky decisions in healthy adults. Journal of Neuroscience, 32(38), 13032. https://doi.org/10.1523/JNEUROSCI.0151-12.2012

Campbell-Meiklejohn, D., Simonsen, A., Jensen, M., Wohlert, V., Gjerløff, T., Scheel-Kruger, J., Møller, A., Frith, C. D. & Roepstorff, A. (2012). Modulation of Social Influence by Methylphenidate. Neuropsychopharmacology. https://doi.org/10.1038/npp.2011.337

Callesen, M. B. & Møller, A. (2009). Parkinsons sygdom og ludomani. Parkinson Nyt, 29(1), 10-11.

Callesen, M. B., Scheel-Krüger, J., Kringelbach, M. L. & Møller, A. (2013). A Systematic Review of Impulse Control Disorders in Parkinson's Disease. Journal of Parkinson's Disease, 3(2), 105-138. https://doi.org/10.3233/JPD-120165

Callesen, M. B., Hansen, K. V., Gjedde, A., Linnet, J. & Møller, A. (2013). Dopaminergic and clinical correlates of pathological gambling in Parkinson's disease: A case report. Frontiers in Behavioral Neuroscience, 7(95), 1-8. https://doi.org/10.3389/fnbeh.2013.00095

Callesen, M. B., Weintraub, D., Damholdt, M. F. & Møller, A. (2014). Impulsive and compulsive behaviors among Danish patients with Parkinson’s diseass: Prevalence, depression, and personality. Parkinsonism & Related Disorders, 20(1), 22-26. https://doi.org/10.1016/j.parkreldis.2013.09.006

Callesen, M. B., Weintraub, D., Damholdt, M. F. & Møller, A. (2013). Prevalence of impulse control disorders in Danish patients with Parkinson's disease. Movement Disorders, 28(Suppl 1), 347. http://www.mdsabstracts.com/default.asp

Cai, X. L., Xie, D. J., Madsen, K. H., Wang, Y. M., Bögemann, S. A., Cheung, E. F. C., Møller, A. & Chan, R. C. K. (2020). Generalizability of machine learning for classification of schizophrenia based on resting-state functional MRI data. Human Brain Mapping, 41(1), 172-184. https://doi.org/10.1002/hbm.24797

Cai, X. L., Wang, Y. M., Wang, Y., Zhou, H. Y., Huang, J., Wang, Y., Lui, S. S. Y., Møller, A., Hung, K. S. Y., Mak, H. K. F., Sham, P. C., Cheung, E. F. C. & Chan, R. C. K. (2021). Neurological Soft Signs Are Associated with Altered Cerebellar-Cerebral Functional Connectivity in Schizophrenia. Schizophrenia Bulletin, 47(5), 1452-1462. https://doi.org/10.1093/schbul/sbaa200

Cai, X. L., Pu, C. C., Zhou, S. Z., Wang, Y., Huang, J., Lui, S. S. Y., Moller, A., Cheung, E. F. C., Madsen, K. H., Xue, R., Yu, X. & Chan, R. C. K. (2023). Anterior cingulate glutamate levels associate with functional activation and connectivity during sensory integration in schizophrenia: a multimodal ¹H-MRS and fMRI study. Psychological Medicine, 53(11), 4904-4914. https://doi.org/10.1017/S0033291722001817

Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T. & Banati, R. B. (2001). In-vivo measurement of activated microglia in dementia. Lancet, 358(9280), 461-467. https://doi.org/10.1016/S0140-6736(01)05625-2

Burn, D. J., Rinne, J. O., Quinn, N. P., Lees, A. J., Marsden, C. D. & Brooks, D. J. (1995). Striatal opioid receptor binding in parkinson's disease, striatonigral degeneration and steele-richardson-olszewski syndrome: A [¹¹c]diprenorphine PET study. Brain, 118(4), 951-958. https://doi.org/10.1093/brain/118.4.951

Burn, D. J., Sawle, G. V. & Brooks, D. J. (1994). Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: Discriminant analysis of striatal ¹⁸F-dopa PET data. Journal of Neurology Neurosurgery and Psychiatry, 57(3), 278-284. https://doi.org/10.1136/jnnp.57.3.278

Burn, D. J., Mark, M. H., Playford, E. D., Maraganore, D. M., Zimmerman, T. R., Duvoisin, R. C., Harding, A. E., Marsden, C. D. & Brooks, D. J. (1992). Parkinson's disease in twins studied with 18–dopa and positron emission tomography. Neurology, 42(10), 1894-1900. https://doi.org/10.1212/wnl.42.10.1894

Buckley, C. J., Sherwin, P. F., Smith, A. P. L., Wolber, J., Weick, S. M. & Brooks, D. J. (2017). Validation of an electronic image reader training programme for interpretation of [F-18]flutemetamol beta- amyloid PET brain images. Nuclear Medicine Communications, 38(3), 234-241. https://doi.org/10.1097/MNM.0000000000000633

Brunt, E. R., Brooks, D. J., Korczyn, A. D., Montastruc, J. L. & Stocchi, F. (2002). A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa. Journal of Neural Transmission, 109(4), 489-502. https://doi.org/10.1007/s007020200040

Brundin, P., Pogarell, O., Hagell, P., Piccini, P., Widner, H., Schrag, A., Kupsch, A., Crabb, L., Odin, P., Gustavii, B., Björklund, A., Brooks, D. J., Marsden, C. D., Oertel, W. H., Quinn, N. P., Rehncrona, S. & Lindvall, O. (2000). Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain, 123(7), 1380-1390.

Brooks, D. J. (2012). Can imaging separate multiple system atrophy from Parkinson's disease? Movement Disorders, 27(1), 3-5. https://doi.org/10.1002/mds.24046

Brooks, D. J. (2012). Parkinson's disease: diagnosis. Parkinsonism & Related Disorders, 18 Suppl 1, S31-3. https://doi.org/10.1016/S1353-8020(11)70012-8

Brooks, D. J. & Pavese, N. (2011). Imaging biomarkers in Parkinson's disease. Progress in Neurobiology, 95(4), 614-28. https://doi.org/10.1016/j.pneurobio.2011.08.009

Brooks, D. J. (2016). Molecular imaging of dopamine transporters. Ageing Research Reviews, 30, 114-121. https://doi.org/10.1016/j.arr.2015.12.009

Brooks, D. J. & Tambasco, N. (2016). Imaging Synucleinopathies. Movement Disorders, 31(6), 814-829. https://doi.org/10.1002/mds.26547

Brooks, D. J. (2010). Examining Braak's hypothesis by imaging Parkinson's disease. Movement Disorders, 25(SUPPL. 1). https://doi.org/10.1002/mds.22720

Brooks, D. J. (2010). Imaging dopamine transporters in Parkinsons disease. Biomarkers in Medicine, 4(5), 651-660. https://doi.org/10.2217/bmm.10.86

Brooks, D. J. (2010). Imaging approaches to Parkinson disease. Journal of Nuclear Medicine, 51(4), 596-609. https://doi.org/10.2967/jnumed.108.059998

Brooks, D. J., Papapetropoulos, S., Vandenhende, F., Tomic, D., He, P., Coppell, A. & O'Neill, G. (2010). An open-label, positron emission tomography study to assess adenosine A2A brain receptor occupancy of vipadenant (BIIB014) at steady-state levels in healthy male volunteers. Clinical Neuropharmacology, 33(2), 55-60. https://doi.org/10.1097/WNF.0b013e3181d137d2

Brooks, D. J. & Pavese, N. (2010). Continuous dopaminergic stimulation in Parkinson's disease - What have we learned from positron-emission tomography? European Neurological Review, 5(1), 22-25. https://doi.org/10.17925/ENR.2010.05.01.22

Brooks, D. J. (2009). Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography. Movement Disorders, 24(SUPPL. 2). https://doi.org/10.1002/mds.22581

Brooks, D. J. & Seppi, K. (2009). Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Movement Disorders, 24(7), 949-964. https://doi.org/10.1002/mds.22413

Brooks, D. J. (2008). The role of structural and functional imaging in Parkinsonian states with a description of PET technology. Seminars in Neurology, 28(4), 435-445. https://doi.org/10.1055/s-0028-1083690

Brooks, D. J., Leinonen, M., Kuoppamäki, M. & Nissinen, H. (2008). Five-year efficacy and safety of levodopa/DDCI and entacapone in patients with Parkinson's disease. Journal of Neural Transmission, 115(6), 843-849. https://doi.org/10.1007/s00702-008-0025-8

Brooks, D. J. (2008). Technology Insight: Imaging neurodegeneration in Parkinson's disease. Nature Clinical Practice Neurology, 4(5), 267-277. https://doi.org/10.1038/ncpneuro0773

Brooks, D. J. (2007). Imaging non-dopaminergic function in Parkinson's disease. Molecular Imaging and Biology, 9(4), 217-222. https://doi.org/10.1007/s11307-007-0084-5

Brooks, D. J., Agid, Y., Eggert, K., Widner, H., Østergaard, K. & Holopainen, A. (2005). Treatment of end-of-dose wearing-off in Parkinson's disease: Stalevo® (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess®/Comtan® (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment. European Neurology, 53(4), 197-202. https://doi.org/10.1159/000086479

Brooks, D. J. & Sagar, H. (2003). Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: A randomised, placebo controlled, double blind, six month study. Journal of Neurology Neurosurgery and Psychiatry, 74(8), 1071-1079. https://doi.org/10.1136/jnnp.74.8.1071

Brooks, D. J. & Piccini, P. (2006). Imaging in Parkinson's Disease: The Role of Monoamines in Behavior. Biological Psychiatry, 59(10), 908-918. https://doi.org/10.1016/j.biopsych.2005.12.017

Brooks, D. J. & Lammertsma, A. A. (2005). Imaging studies in drug development: Parkinson's disease. Drug Discovery Today: Technologies, 2(4), 317-321. https://doi.org/10.1016/j.ddtec.2005.11.001

Brooks, D. J. (2004). Neuroimaging in Parkinson's Disease. NeuroRx, 1(2), 243-254. https://doi.org/10.1602/neurorx.1.2.243

Brooks, D. J., Frey, K. A., Marek, K. L., Oakes, D., Paty, D., Prentice, R., Shults, C. W. & Stoessl, A. J. (2003). Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease. Experimental Neurology, 184(SUPPL. 1). https://doi.org/10.1016/j.expneurol.2003.08.008

Brooks, D. J., Koller, Olanow, Hauser, Reinikainen, Poewe, Hubble & Stocchi (2004). Safety and tolerability of COMT inhibitors. Neurology, 62(1 SUPPL. 1).

Brooks, D. J. (2003). PET studies on the function of dopamine in health and Parkinson's disease. Annals of the New York Academy of Sciences, 991, 22-35.

Brooks, D. J. (2001). Functional imaging studies on dopamine and motor control. Journal of Neural Transmission, 108(11), 1283-1298. https://doi.org/10.1007/s007020100005

Brooks, D. J. (2002). Diagnosis and management of atypical Parkinsonian syndromes. Neurology in Practice, 72(1).

Brooks, D. J. (2000). Imaging basal ganglia function. Journal of Anatomy, 196(4), 543-554. https://doi.org/10.1017/S0021878299005993

Brooks, D. J. & Samuel, M. (2000). The effects of surgical treatment of Parkinson's disease on brain function: PET findings. Neurology, 55(12 SUPPL. 6).

Brooks, D. J. (2000). PET studies and motor complications in Parkinson's disease. Trends in Neurosciences, 23(10 SUPPL.). https://doi.org/10.1016/S1471-1931(00)00016-1

Brooks, D. J. (2000). Dopamine agonists: Their role in the treatment of Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry, 68(6), 685-689. https://doi.org/10.1136/jnnp.68.6.685

Brooks, D. J. (2000). Functional imaging studies in corticobasal degeneration. Advances in neurology, 82, 209-215.

Brooks, D. J. (2000). Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease. Journal of Neurology, Supplement, 247(2), 11-18.

Brooks, D. J. (1999). Functional imaging of Parkinson's disease: Is it possible to detect brain areas for specific symptoms. Journal of Neural Transmission, Supplement, (56), 139-153.

Brooks, D. J. (2000). Monitoring neuroprotection and restorative therapies in Parkinson's disease with PET. Journal of Neural Transmission, Supplement, (60), 125-137.

Brooks, D. J., Piccini, P., Turjanski, N. & Samuel, M. (2000). Neuroimaging of dyskinesia. Annals of Neurology, 47(4 SUPPL. 1).

Brooks, D. J., Abbott, R. J., Lees, A. J., Martignoni, E., Philcox, D. V., Rascol, O., Roos, R. A. C. & Sagar, H. J. (1998). A placebo-controlled evaluation of ropinirole, a novel D₂ agonist, as sole dopaminergic therapy in Parkinson's disease. Clinical Neuropharmacology, 21(2), 101-107.

Brooks, D. J. (1995). Parkinson's disease-a single clinical entity? QUARTERLY JOURNAL OF MEDICINE, 88(2), 81-91.

Brooks, D. J., Salmon, E. P., Mathias, C. J., Quinn, N., Leenders, K. L., Bannister, R., Marsden, C. D. & Frackowiak, R. S. J. (1990). The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and parkinson's disease, studied with pet. Brain, 113(5), 1539-1552. https://doi.org/10.1093/brain/113.5.1539

Brooks, D. J., Luthert, P., Gadian, D. & Marsden, C. D. (1989). Does signal-attenuation of high-field T₂-weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T₂ values and iron levels. Journal of Neurology Neurosurgery and Psychiatry, 52(1), 108-111. https://doi.org/10.1136/jnnp.52.1.108

Brooks, D. J. (1995). The role of the basal ganglia in motor control: contributions from PET. Journal of the Neurological Sciences, 128(1), 1-13. https://doi.org/10.1016/0022-510X(94)00206-4

Brooks, D. J., Turjanski, N., Sawle, G. V., Playford, E. D. & Lees, A. J. (1992). PET studies on the integrity of the pre and postsynaptic dopaminergic system in Tourette syndrome. Advances in neurology, 58, 227-231.

Brooks, D. J., Beaney, R. P., Lammertsma, A. A., Herold, S., Turton, D. R., Luthra, S. K., Frackowiak, R. S., Thomas, D. G., Marshall, J. & Jones, T. (1986). Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumours studied using [¹¹C]3-O-methyl-D-glucose and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism, 6(2), 230-239. https://doi.org/10.1038/jcbfm.1986.36

Brooks, D. J., Beaney, R. P., Thomas, D. G. T., Marshall, J. & Jones, T. (1986). Studies on regional cerebral pH in patients with cerebral tumours using continuous inhalation of ¹¹CO₂ and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism, 6(5), 529-535. https://doi.org/10.1038/jcbfm.1986.98

Brooks, D. J., Gibbs, J. S. R., Sharp, P., Herold, S., Turton, D. R., Luthra, S. K., Kohner, E. M., Bloom, S. R. & Jones, T. (1986). Regional cerebral glucose transport in insulin-dependent diabetic patients studied using [¹¹C]3-O-methyl-D-glucose and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism, 6(2), 240-244. https://doi.org/10.1038/jcbfm.1986.37

Brooks, D. J., Beaney, R. P., Powell, M., Leenders, K. L., Crockard, H. A., Thomas, D. G. T., Marshall, J. & Jones, T. (1986). Studies on cerebral oxygen metabolism, blood flow, and blood volume, in patients with hydrocephalus before and after surgical decompression, using positron emission tomography. Brain, 109(4), 613-628. https://doi.org/10.1093/brain/109.4.613

Brooks, D. J. (1998). The early diagnosis of Parkinson's disease. Annals of Neurology, 44(3 SUPPL. 1).

Brooks, D. J. (1997). Advances in imaging Parkinson's disease. Current Opinion in Neurology, 10(4), 327-331. https://doi.org/10.1097/00019052-199708000-00008

Brooks, D. J. (1996). Basal ganglia function during normal and parkinsonian movement. PET activation studies. Advances in neurology, 69, 433-441.

Brooks, D. J., Beaney, R. P., Lammertsma, A. A., Turton, D. R., Marshall, J., Thomas, D. G. T. & Jones, T. (1986). Studies on regional cerebral haematocrit and blood flow in patients with cerebral tumours using positron emission tomography. Microvascular Research, 31(3), 267-276. https://doi.org/10.1016/0026-2862(86)90016-6

Brooks, D. J., Lammertsma, A. A., Beaney, R. P., Leenders, K. L., Buckingham, P. D., Marshall, J. & Jones, T. (1984). Measurement of regional cerebral pH in human subjects using continuous inhalation of ¹¹CO₂ and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism, 4(3), 458-465. https://doi.org/10.1038/jcbfm.1984.65

Brooks, D. J., Beaney, R. P., Lammertsma, A. A., Leenders, K. L., Horlock, P. L., Kensett, M. J., Marshall, J., Thomas, D. G. & Jones, T. (1984). Quantitative measurement of blood-brain barrier permeability using rubidium-82 and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism, 4(4), 535-545. https://doi.org/10.1038/jcbfm.1984.78

Brooks, D. J. (1993). Functional imaging in relation to parkinsonian syndromes. Journal of the Neurological Sciences, 115(1), 1-17. https://doi.org/10.1016/0022-510X(93)90061-3

Brooks, D. J., Carr, D. H. & Legg, N. J. (1987). The role of delayed computed tomographic scanning using high dose of contrast material in detecting cerebral demyelination in patients with multiple sclerosis in relapse and remission. British Journal of Radiology, 60(711), 295-297. https://doi.org/10.1259/0007-1285-60-711-295

Brooks, D. J. (1989). Positron emission tomographic studies of the subcortical degenerations and dystonia. Seminars in Neurology, 9(4), 351-359. https://doi.org/10.1055/s-2008-1041345

Brooks, D. J. (1991). PET: Its clinical role in neurology. Journal of Neurology Neurosurgery and Psychiatry, 54(1), 1-5. https://doi.org/10.1136/jnnp.54.1.1

Brooks, D. J. (1998). Positron emission tomography studies in movement disorders. Neurosurgery Clinics of North America, 9(2), 263-281.

Brooks, D. J. (1997). PET and SPECT studies in Parkinson's disease. Bailliere's Clinical Neurology, 6(1), 69-87.

Brooks, D. J. (1994). PET studies in progressive supranuclear palsy. Journal of Neural Transmission, Supplement, (42), 119-134.

Brooks, D. J. (1996). Functional imaging techniques in the diagnosis of non-Alzheimer dementias. Journal of Neural Transmission, Supplement, (47), 155-167.

Brooks, D. J. (1993). PET studies on the early and differential diagnosis of Parkinson's disease. Neurology, 43(12 II SUPPL. 6).

Brooks, D. J., Torjanski, N. & Burn, D. J. (1995). Ropinirole in the symptomatic treatment of Parkinson's disease. Journal of Neural Transmission, Supplement, (45), 231-238.

Brooks, D. J., Beaney, R. P. & Thomas, D. G. T. (1986). The role of Positron Emission Tomography in the study of cerebral tumors. Seminars in Oncology, 13(1), 83-93.

Brooks, D. J. (1991). Detection of preclinical Parkinson's disease with PET. Geriatrics, 46 Suppl 1, 25-30.

Brooks, D. J. (1992). PET: Motor function and dysfunction. Movement Disorders, 7(1 S), 20. https://doi.org/10.1002/mds.870070521

Brooks, D. J. (1991). The clinical role of PET in cerebrovascular disease. Neurosurgical Review, 14(2), 91-96. https://doi.org/10.1007/BF00313030

Brooks, D. J. (2021). Imaging Familial and Sporadic Neurodegenerative Disorders Associated with Parkinsonism. Neurotherapeutics, 18(2), 753-771. https://doi.org/10.1007/s13311-020-00994-4

Brooks, D. J. (2021). Future Imaging in Dementia. Seminars in Nuclear Medicine, 51(3), 303-308. https://doi.org/10.1053/j.semnuclmed.2020.12.001

Brooks, D. J. (2015). Neuroimaging in Parkinson's disease: a future perspective. Neurodegenerative Disease Management, 5(2), 105-108. https://doi.org/10.2217/nmt.14.56

Brooks, D. J., Playford, E. D., Ibanez, V., Sawle, G. V., Thompson, P. D., Findley, L. & Marsden, C. D. (1993). Essential tremor and pd. Neurology, 43(7), 1448-1449. https://doi.org/10.1212/wnl.43.7.1448

Brooks, D. J., Frackowiak, R. S. J., Lammertsma, A. A., Herold, S., Leenders, K. L., Selwyn, A. P., Turton, D. R., Brady, F. & Jones, T. (1986). A comparison between regional cerebral blood flow measurements obtained in human subjects using ¹¹C‐methylalbumin microspheres, the C¹⁵O₂ steady‐state method, and positron emission tomography. Acta Neurologica Scandinavica, 73(4), 415-422. https://doi.org/10.1111/j.1600-0404.1986.tb03298.x

Brooks, D. J., Beaney, R. P., Leenders, K. L., Marshall, J., Thomas, D. J. & Jones, T. (1985). Regional cerebral oxygen utilization, blood flow, and blood volume in benign intracranial hypertension studied by positron emission tomography. Neurology, 35(7), 1030-1034. https://doi.org/10.1212/wnl.35.7.1030

Brooks, D. J., Leenders, K. L., Head, G., Marshall, J., Legg, N. J. & Jones, T. (1984). Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry, 47(11), 1182-1191. https://doi.org/10.1136/jnnp.47.11.1182

Bro, A., Sørensen, J. C. H., Nielsen, M. S., Rosendahl, F., Deding, D., Ettrup, K. S., Jensen, K. N., Jørgensen, R. L., Glud, A. N., Meidahl, A. C. N., Meier, K., Moberg Fitting, L., Møller, A., Alstrup, A. K. O., Østergaard, L. & Bjarkam, C. R. (2012). The Göttingen minipig in translational neuroscience. Ellegaard Newsletter, 38, 8-9.

Brett, M., Stein, J. F. & Brooks, D. J. (1998). The role of the lateral premotor cortex in conditional and imitated praxis. NeuroImage, 7(4 PART II).

Brett, M., Jenkins, I. H., Stein, J. F. & Brooks, D. J. (1997). Movement selection without preparation does not activate the SMA. NeuroImage, 5(4 PART II).

Breen, D. P., Nombela, C., Vuono, R., Jones, P. S., Fisher, K., Burn, D. J., Brooks, D. J., Reddy, A. B., Rowe, J. B. & Barker, R. A. (2016). Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease. Movement Disorders, 31(7), 1062-1066. https://doi.org/10.1002/mds.26592

Botzel, K., Schulze, S., Jahanshahi, M., Jenkins, H., Brown, R. G., Marsden, C. D., Passingham, R. E. & Brooks, D. J. (1996). Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects [1]. Brain, 119(3), 1045-1048. https://doi.org/10.1093/brain/119.3.1045

Borghammer, P., Knudsen, K., Østergaard, K., Danielsen, E. H., Pavese, N., Arveschoug, A., Bluhme, H., Bode, M. & Morsing, A. (2014). Combined DaT imaging and olfactory testing for differentiating parkinsonian disorders. International Journal of Clinical Practice, 68(11), 1345-51. https://doi.org/10.1111/ijcp.12445

Borghammer, P., Knudsen, K. & Brooks, D. J. (2016). Imaging Systemic Dysfunction in Parkinson's Disease. Current Neurology and Neuroscience Reports, 16(6), 51. Article 51. https://doi.org/10.1007/s11910-016-0655-4

Borghammer, P., Knudsen, K., Fedorova, T. D. & Brooks, D. J. (2017). Imaging Parkinson's disease below the neck. npj Parkinson's Disease , 3(1), 15. Article 0017. https://doi.org/10.1038/s41531-017-0017-1

Bonuccelli, U. & Pavese, N. (2007). Role of dopamine agonists in Parkinson's disease: An update. Expert Review of Neurotherapeutics, 7(10), 1391-1399. https://doi.org/10.1586/14737175.7.10.1391

Bonuccelli, U. & Pavese, N. (2006). Dopamine agonists in the treatment of Parkinson's disease. Expert Review of Neurotherapeutics, 6(1), 81-89. https://doi.org/10.1586/14737175.6.1.81

Bonuccelli, U., Pavese, N., Lucetti, C., Renna, M. R., Gambaccini, G., Bernardini, S., Canapicchi, R., Carrozzi, L. & Murri, L. (1999). Late whiplash syndrome: A clinical and magnetic resonance imaging study. Functional Neurology, 14(4), 219-225.

Bonuccelli, U., D'Avino, C., Caraccio, N., Del Guerra, P., Casolaro, A., Pavese, N., Del Dotto, P. & Monzani, F. (1999). Thyroid function and autoimmunity in Parkinson's disease: A study of 101 patients. Parkinsonism and Related Disorders, 5(1-2), 49-53. https://doi.org/10.1016/S1353-8020(99)00010-3

Bonuccelli, U., Nuti, A., Lucetti, C., Pavese, N., Dell'Agnello, G. & Muratorio, A. (1996). Amitriptyline and dexamethasone combined treatment in drug-induced headache. Cephalalgia, 16(3), 197-200. https://doi.org/10.1046/j.1468-2982.1996.1603197.x

Bonuccelli, U., Piccini, P., Del Dotto, P., Pavese, N., D'Antonio, P. & Muratorio, A. (1992). Apomorphine test in de novo Parkinson's disease. Functional Neurology, 7(4), 295-298.

Boecker, H. & Brooks, D. J. (2011). Resting tremor in Parkinson disease: Is the pallidum to blame? Annals of Neurology, 69(2), 229-231. https://doi.org/10.1002/ana.22358

Boecker, H., Weindl, A., Brooks, D. J., Ceballos-Baumann, A. O., Liedtke, C., Miederer, M., Sprenger, T., Wagner, K. J. & Miederer, I. (2010). GABAergic dysfunction in essential tremor: An¹¹C-flumazenil PET study. Journal of Nuclear Medicine, 51(7), 1030-1035. https://doi.org/10.2967/jnumed.109.074120

Boecker, H., Ceballos-Baumann, A. O., Bartenstein, P., Dagher, A., Forster, K., Haslinger, B., Brooks, D. J., Schwaiger, M. & Conrad, B. (2002). A H₂ ¹⁵O positron emission tomography study on mental imagery of movement sequences - The effect of modulating sequence length and direction. NeuroImage, 17(2), 999-1009. https://doi.org/10.1016/S1053-8119(02)91139-0

Boecker, H., Ceballos-Baumann, A. O., Bartenstein, P., Siebner, H. R., Forster, K., Dagher, A., Haslinger, B., Brooks, D. J. & Conrad, B. (1999). PET imaging of motor sequence control: Pure motor imagination of increasingly complex finger sequences, A parametric 3D H2 15O PET study. NeuroImage, 9(6 PART II).

Boecker, H. & Brooks, D. J. (1998). Functional imaging of tremor. Movement Disorders, 13(SUPPL. 3), 64-72.

Boecker, H., Dagher, A., Ceballos-Baumann, A. O., Passingham, R. E., Samuel, M., Friston, K. J., Poline, J. B., Dettmers, C., Conrad, B. & Brooks, D. J. (1998). Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: Investigations with H₂ ¹⁵O PET. Journal of Neurophysiology, 79(2), 1070-1080. https://doi.org/10.1152/jn.1998.79.2.1070

Boecker, H., Wills, A. J., Ceballos-Baumann, A., Samuel, M., Thomas, D. G. T., Marsden, C. D. & Brooks, D. J. (1997). Stereotactic thalamotomy in tremor-dominant parkinson's disease: An H₂ ¹⁵O PET motor activation study. Annals of Neurology, 41(1), 108-111. https://doi.org/10.1002/ana.410410118

Boecker, H., Wills, A. J., Ceballos-Baumann, A., Samuel, M., Thompson, P. D., Findley, L. J. & Brooks, D. J. (1996). The effect of ethanol on alcohol-responsive essential tremor: A position emission tomography study. Annals of Neurology, 39(5), 650-658. https://doi.org/10.1002/ana.410390515

Boecker, H., Dagher, A., Ceballos-Baumann, A. O., Passingham, R. E., Samuel, M., Friston, K. J., Poline, J. B., Dettmers, C., Conrad, B. & Brooks, D. J. (1998). Erratum: Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: Investigations with H₂ ¹⁵O PET (Journal of Neurophysiology (February 1998) 79 (1070-1080)). Journal of Neurophysiology, 79(4).

Blunt, S. B., Fuller, G., Kennard, C. & Brooks, D. (1994). Orolingual dystonia with “tip of the tongue” geste. Movement Disorders, 9(4), 466. https://doi.org/10.1002/mds.870090417

Blunt, S. B., Brooks, D. J. & Kennard, C. (1994). Steroid‐responsive chorea in childhood following cardiac transplantation. Movement Disorders, 9(1), 112-114. https://doi.org/10.1002/mds.870090123

Bjarkam, C., Nielsen, M. S., Glud, A. N., Rosendal, F., Mogensen, P., Bender, D., Doudet, D., Møller, A. & Sørensen, J. C. H. (2008). Neuromodulation in a minipig MTTP model of Parkinson disease. British Journal of Neurosurgery, 22/1, 9-12.

Bjarkam, C. R., Nielsen, M. S., GLUD, AN., Rosendal, F., Mogensen, P., Bender, D., Doudet, D., Møller, A. & Sørensen, J. C. (2008). Neuromodulation in a minipig MPTP model of Parkinson disease. British Journal of Neurosurgery, 22 Suppl 1, S9-12. https://doi.org/10.1080/02688690802448285

Binda, K. H., Lillethorup, T. P., Real, C. C., Bærentzen, S. L., Nielsen, M. N., Orlowski, D., Brooks, D. J., Chacur, M. & Landau, A. M. (2021). Exercise protects synaptic density in a rat model of Parkinson's disease. Experimental Neurology, 342, 113741. Article 113741. https://doi.org/10.1016/j.expneurol.2021.113741

Binda, K. H., Real, C. C., Simonsen, M. T., Grove, E. K., Bender, D., Gjedde, A., Brooks, D. J. & Landau, A. M. (2025). Acute transcutaneous auricular vagus nerve stimulation modulates presynaptic SV2A density in healthy rat brain: An in vivo microPET study. Psychophysiology, 62(1), Article e14709. https://doi.org/10.1111/psyp.14709

Bhatnagar, M., Cintra, A., Chadi, G., Lindberg, J., Oitzl, M., De Kloet, E. R., Møller, A., Agnati, L. F. & Fuxe, K. (1997). Neurochemical changes in the hippocampus of the brown norway rat during aging. Neurobiology of Aging, 18, 319-327.

Bhatia, K., Brooks, D. J., Burn, D. J., Clarke, C. E., Grosset, D. G., MacMahon, D. G., Fer, J. P., Schapira, A. H. V., Stewart, D. & Williams, A. C. (2001). Updated guidelines for the management of Parlcinson's disease. Hospital Medicine, 62(8), 456-470. https://doi.org/10.12968/hosp.2001.62.8.1621

Bhatia, K. P., Turjanski, N., Brooks, D. J., Marsden, C. D. & Thrush, D. (1996). The usefulness of functional imaging in movement disorders: An illustrative case [8]. Journal of Neurology Neurosurgery and Psychiatry, 60(3), 353-354. https://doi.org/10.1136/jnnp.60.3.353

Bhatia, K., Brooks, D. J., Burn, D. J., Clarke, C. E., Playfer, J., Sawle, G. V., Schapira, A. H. V., Stewart, D. & Williams, A. C. (1998). Guidelines for the management of Parkinson's disease. Hospital Medicine, 59(6), 469-480.

Betzer, C., Lassen, L. B., Olsen, A., Kofoed, R. H., Reimer, L., Gregersen, E., Zheng, J., Calì, T., Gai, W.-P., Chen, T., Moeller, A., Brini, M., Fu, Y., Halliday, G., Brudek, T., Aznar, S., Pakkenberg, B., Andersen, J. P. & Jensen, P. H. (2018). Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation. EMBO Reports, 19(5), Article e44617. https://doi.org/10.15252/embr.201744617

Best, L., Ghadery, C., Pavese, N., Tai, Y. F. & Strafella, A. P. (2019). New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease. Current Neurology and Neuroscience Reports, 19(5), Article 24. https://doi.org/10.1007/s11910-019-0934-y

Bertelsen, F., Møller, A., Folloni, D., Drasbek, K. R., Scheel-Krüger, J. & Landau, A. M. (2017). Increased GABA_A receptor binding in amygdala after prenatal administration of valproic acid to rats. Acta Neuropsychiatrica, 29(5), 309-3014. https://doi.org/10.1017/neu.2016.59

Bertelsen, F., Folloni, D., Møller, A., Landau, A. M., Scheel-Krüger, J. & Winterdahl, M. (2017). Suppressed play behaviour and decreased oxytocin receptor binding in the amygdala after prenatal exposure to low-dose valproic acid. Behavioural Pharmacology, 28(6), 450-457. https://doi.org/10.1097/FBP.0000000000000316

Bertelsen, F., Landau, A. M., Vase, K. H., Jacobsen, J., Scheel-Krüger, J. & Møller, A. (2018). Acute in vivo effect of valproic acid on the GABAergic system in rat brain: A [C-11]Ro15-4513 microPET study. Brain Research, 1680, 110-114. https://doi.org/10.1016/j.brainres.2017.12.018

Berding, G., Odin, P., Brooks, D. J., Nikkhah, G., Matthies, C., Peschel, T., Shing, M., Kolbe, H., van den Hoff, J., Fricke, H., Dengler, R., Samii, M. & Knapp, W. H. (2001). Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [¹⁸F]FDG-PET. Movement Disorders, 16(6), 1014-1022. https://doi.org/10.1002/mds.1212

Berding, G., Brücke, T., Odin, P., Brooks, D. J., Kolbe, H., Gielow, P., Harke, H., Knoop, B. O., Dengler, R. & Knapp, W. H. (2003). [¹²³I]β-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy. Nuklearmedizin, 42(1), 31-38.

Berardelli, A., Wenning, G. K., Antonini, A., Berg, D., Bloem, B. R., Bonifati, V., Brooks, D., Burn, D. J., Colosimo, C., Fanciulli, A., Ferreira, J., Gasser, T., Grandas, F., Kanovsky, P., Kostic, V., Kulisevsky, J., Oertel, W., Poewe, W., Reese, J. P. ... Vidailhet, M. (2013). EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease. European Journal of Neurology, 20(1), 16-34. https://doi.org/10.1111/ene.12022

Bennekou, P., Pedersen, O., Møller, A. & Christophersen, P. (2000). Volume control in sickle cells is facilitated by the novel anion conductance inhibitor NS1652. Blood, 95, 1842-1848.

Bellini, G., Best, L. A., Brechany, U., Mills, R. & Pavese, N. (2020). Clinical Impact of Deep Brain Stimulation on the Autonomic System in Patients with Parkinson's Disease. Movement Disorders Clinical Practice, 7(4), 373-382. https://doi.org/10.1002/mdc3.12938

Beaney, R. P., Brooks, D. J., Leenders, K. L., Thomas, D. G., Jones, T. & Halnan, K. E. (1985). Blood flow and oxygen utilisation in the contralateral cerebral cortex of patients with untreated intracranial tumours as studied by positron emission tomography, with observations on the effect of decompressive surgery. Journal of Neurology Neurosurgery and Psychiatry, 48(4), 310-319. https://doi.org/10.1136/jnnp.48.4.310

Beaney, R. P., Gibbs, J. S. R., Brooks, D. J., McKenzie, C. G., Joplin, G. F. & Jones, T. (1987). Absence of irradiation induced ischaemic temporal lobe damage in patients with pituitary tumours. Journal of Neuro-Oncology, 5(2), 129-137. https://doi.org/10.1007/BF02571301